David Kuraguntla, DO

Dave is the Co-Founder and CEO of Alio, a noninvasive remote monitoring company dedicated to improving the lives of those living with chronic kidney disease (CKD) and other chronic conditions. Dave received his master’s degree from Boston University and was a researcher at the National Institutes of Health. He then went to medical school on an Air Force scholarship. He received his medical degree in osteopathic medicine (D.O.) and was preparing for a surgical residency when he experienced firsthand the need for better technological solutions for those with chronic conditions.

Drawing on his experience, he began to explore the potential of noninvasive wearables for conditions like End Stage Kidney Disease (ESKD) and started Alio. Since then, Alio has secured $35 million in funding to-date and formed key strategic partnerships with organizations including the NHS in the UK, Intermountain, Lifeline and US Renal Care.